$1.92
0.073.62%
At close: -
$1.65
-0.27-13.93%
After Hours: Oct 31, 9:19 AM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for NervGen Pharma in recent months.
Browse guidance and forecast on all stocks.